Morihepamine IV infusion, manufactured by AY Pharma, is an amino acid preparation for liver failure, provided as a 200mL 1 bag injectable drug (YJ code: 3253410A1031). It is indicated for supportive treatment of hepatic encephalopathy syndrome in patients with chronic liver disorder.
Morihepamine IV infusion
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →